Burping on Wegovy: what the evidence says and what you can do

Burping with Wegovy is a recognised gastrointestinal side effect, not a sign that something has gone wrong.
Semaglutide slows gastric emptying, which means food and gas sit in the stomach longer, this is the likely mechanism behind the excess burping.
It is most noticeable after dose increases and typically settles within days to a couple of weeks.
Eating pace, portion size and food choices can all influence how much burping you experience on treatment.

Burping is one of the most commonly reported upper gastrointestinal side effects of Wegovy (semaglutide). The NHS patient information for semaglutide lists eructation — the clinical term for burping — among the known side effects, and participants in the STEP 1 trial reported it at meaningful rates. It tends to peak in the early weeks of treatment and often eases as your body adjusts. These are prescription-only medicines; a clinical assessment determines whether Wegovy is right for you.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

The mechanism, the evidence and practical ways to manage burping on Wegovy

What the STEP 1 trial data and NHS guidance tell us about this side effect

When the STEP 1 trial (68 weeks, nearly 2,000 adults with obesity) was published in the New England Journal of Medicine, gastrointestinal events were the dominant adverse effects recorded. Nausea led the list, but eructation (burping) featured consistently among upper-GI complaints, and participants in the semaglutide arm reported it at higher rates than those on placebo. The NHS medicines page for semaglutide reflects this, listing burping alongside nausea, vomiting, diarrhoea and constipation as effects to expect.

The reason sits in the pharmacology. Semaglutide activates GLP-1 receptors in the gut, which deliberately slows the rate at which your stomach empties. That's partly how it reduces appetite, meals feel more filling, for longer. The trade-off is that gas produced during digestion has more time to accumulate before it clears. Swallowing air while eating (which most people do more than they realise) compounds this. The result: more frequent, sometimes more forceful, burping.

It does not mean the medicine is harming you. For most people, burping on Wegovy is uncomfortable rather than serious, and the pattern tends to improve once your gut adapts to the new gastric-emptying rate. If you are finding the burping particularly disruptive, that is worth mentioning to whoever is overseeing your treatment, a fuller picture of Wegovy's side-effect profile may also put it in context.

Why dose increases bring burping back, and when to take it seriously

A pattern many people notice: burping settles after the first few weeks at one dose, then returns when the next dose begins. This is expected. Each step up in semaglutide concentration re-triggers the gastric-slowing effect more intensely while your system recalibrates. It is not a signal to stop treatment; it is the same adjustment process repeating at a higher level.

That said, persistent or severe upper-abdominal symptoms deserve attention. The MHRA's safety communications on GLP-1 medicines highlight acute pancreatitis as a rare but serious possibility, recognisable by severe, persistent stomach pain that radiates to the back, sometimes with vomiting. Ordinary burping does not look like this. But if upper abdominal pain becomes intense and does not ease, seek medical help promptly rather than waiting to see whether it passes. You can report any suspected side effect through the MHRA's Yellow Card scheme, which helps regulators track real-world safety signals.

For the vast majority of people, burping with Wegovy sits firmly in the "inconvenient but harmless" category, peaking around the time of a dose change and fading within a week or two. A question our prescribers hear fairly often is whether it means the dose is too high, in most cases, it simply means the dose is new.

Practical steps that tend to reduce burping during Wegovy treatment

You may be reading this because the burping is genuinely bothering you, noisy, frequent, and happening at inconvenient moments. That is a reasonable thing to want to fix, and there are adjustments that actually help. None of these replaces clinical advice, but they are consistent with guidance from NHS weight-management services.

Eating pace matters more than most people expect. Semaglutide already extends the time food spends in your stomach; if you eat quickly, you swallow considerably more air, which has nowhere to go except back up. Slowing down (putting cutlery down between bites) reduces swallowed air substantially. Smaller, more frequent meals reduce the pressure on a slower-emptying stomach. Fizzy drinks, including sparkling water, introduce gas directly; cutting them during the adjustment period often makes a noticeable difference within days.

Some people find that fatty or very rich foods trigger more burping, because fat is one of the strongest signals for slowing gastric emptying. Leaning towards lighter meals while you are adapting to a new dose can smooth the transition. Chewing food thoroughly (which sounds obvious but is genuinely underrated) reduces the gas load before it reaches the stomach. If you are looking at burping as a semaglutide side effect and want to understand it more fully, that covers the underlying causes in greater depth, while information on how to manage burping specifically on Wegovy covers these adjustments in more detail.

If you are considering Wegovy and wondering whether side effects like this make it the wrong choice, the honest answer is that they affect people differently. A full look at how Wegovy works and what treatment involves gives a more complete picture before you decide anything. Treatment is available only on prescription, following a clinical assessment that weighs your individual circumstances. If you are already on treatment and the burping is severe or not settling, speak to your prescribing team, that is exactly what they are there for.

For those thinking about whether a private prescribing service might work for them, understanding your options for accessing Wegovy in the UK is a useful starting point. Or, if you are ready to talk to a prescriber, you can check your eligibility through a free consultation, reviewed the same day by a GPhC-registered prescriber, not a form-processing algorithm.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions